The estimated Net Worth of Joseph Driscoll is at least $494 Thousand dollars as of 15 January 2019. Joseph Driscoll owns over 15,000 units of Quanterix Corp stock worth over $234,013 and over the last 18 years Joseph sold QTRX stock worth over $259,862.
Joseph has made over 9 trades of the Quanterix Corp stock since 2010, according to the Form 4 filled with the SEC. Most recently Joseph exercised 15,000 units of QTRX stock worth $130,200 on 15 January 2019.
The largest trade Joseph's ever made was exercising 25,000 units of Quanterix Corp stock on 15 November 2018 worth over $217,000. On average, Joseph trades about 8,479 units every 185 days since 2007. As of 15 January 2019 Joseph still owns at least 19,388 units of Quanterix Corp stock.
You can see the complete history of Joseph Driscoll stock trades at the bottom of the page.
Joseph's mailing address filed with the SEC is 5 DICARLO ROAD, , HOPKINTON, MA, 01748.
Over the last 7 years, insiders at Quanterix Corp have traded over $25,118,881 worth of Quanterix Corp stock and bought 1,481,095 units worth $18,701,541 . The most active insiders traders include David R Walt, Paul M Meister, and Keith Crandell. On average, Quanterix Corp executives and independent directors trade stock every 7 days with the average trade being worth of $100,483. The most recent stock trade was executed by Masoud Toloue on 13 August 2024, trading 19,000 units of QTRX stock currently worth $207,100.
quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).
Quanterix Corp executives and other stock owners filed with the SEC include: